--- title: Investor & Venture Support - AHRM Inc description: diligence/valuation services --- [AHRM Inc.](https://www.ahrminc.com/) - [HEOR Services](https://www.ahrminc.com/#services) - [Evidence Sources](https://www.ahrminc.com/#sources) - [Investor Support](https://www.ahrminc.com/investor-support) - [Events & Publications](https://www.ahrminc.com/#publications) - [Contact](https://www.ahrminc.com/investor-support#contact) ☰ [← Back to AHRM Inc.](https://www.ahrminc.com/) # Diligence and valuation, *grounded in evidence.* For investors and life-science ventures, AHRM brings the same rigor we apply to health economics to the questions that decide a deal: does the science hold up, will payers reimburse it, and what is the asset actually worth? We assess the evidence and the market with equal seriousness — and treat every engagement confidentially. [Start a confidential conversation](https://www.ahrminc.com/investor-support#contact) [What we assess](https://www.ahrminc.com/investor-support#services) What we assess ## Investment support across the evidence and the market. Engaged individually or as an integrated diligence package. 01 · Scientific & Clinical Diligence ### Interrogate the science - Clinical evidence & trial design review - Endpoint and probability-of-success assessment - Regulatory pathway risk - Competitive & pipeline landscape 02 · HEOR & Market Access Diligence ### Test the payer case - Reimbursement & coverage likelihood - Value-story and HTA-readiness assessment - Pricing potential & access barriers - Health-economic risk to the thesis 03 · Valuation ### Put a number on it - Asset & company valuation - Risk-adjusted NPV modeling - Comparable transactions & benchmarks - Scenario & sensitivity analysis 04 · Market Sizing & Forecasting ### Size the opportunity - Epidemiology-based market sizing - Revenue & uptake forecasting - Addressable-population modeling - Real-world data to ground assumptions 05 · Reimbursement & Pricing Landscape ### Map the access reality - Payer environment analysis - Pricing benchmarks by market - Coverage-policy & HTA precedent - Access-barrier identification 06 · Investor Narrative & Pitch ### Tell it credibly - Pitch deck & investor narrative development - Evidence-backed value story - Data-room & diligence-response support - Scientific and economic messaging Why AHRM ## We read the science and the market — because we work in both. Most diligence providers are strong on one side: clinical or commercial. AHRM sits at the intersection. We run trials and build the health-economic case for a living, so when we assess an asset for you, we're evaluating it the way the regulators, payers, and HTA bodies who ultimately decide its fate will. - ScienceWe know what a credible trial and endpoint look like - MarketWe know what payers actually reimburse and why - ValueWe translate both into a defensible number - TrustIndependent, confidential, conflict-free assessment How engagements work ## Scoped to your decision and your timeline. STEP 01 ### Scope A confidential conversation to understand the asset, the decision in front of you, and how fast you need answers. STEP 02 ### Assess We evaluate the science, the market-access case, and the numbers — drawing on evidence we can generate and interrogate first-hand. STEP 03 ### Deliver A clear, defensible view you can act on or put in front of your partners — with the underlying assumptions laid bare. Contact ## Start a confidential conversation. Tell us about the asset or the decision, and we'll outline how we can help — and how quickly. [Contact us](mailto:info@ahrminc.com) ### Raleigh, NC +1 919-758-8203 ### Toll-free 1-888-704-5242 ### Back to [AHRM home →](https://www.ahrminc.com/) [HEOR services →](https://www.ahrminc.com/#services) AHRM Inc. — Applied Healthcare Research Management — is a specialty HEOR partner to pharmaceutical, medical device, and investor clients. © 2026 AHRM Inc. [About](https://www.ahrminc.com/about-ahrm-inc) · [Investors](https://www.ahrminc.com/investor-support) · [Blog](https://ahrminc.hs-sites.com/blog)